BSD Medical is Now Pyrexar Medical

The complete line of BSD Hyperthermia products are availble thru Pyrexar Medical

13 new countries 2In our efforts to bring hyperthermia cancer treatment to the world, we are welcoming three new distribution, sales and service companies covering 13 countries.

medvision 250px

MedVision, a division of SADITA Holdings Group, is well known in the areas of cardiology, cardiac surgery and peripheral intervention products. The company will be representing Pyrexar Medical in their home country of Kuwait, as well as, Qatar, Bahrain, Saudi Arabia, Lebanon, Jordan, Egypt, UAE, Oman, Iraq & Iran. This represents a major expansion in the Middle East for Pyrexar and we are looking forward to growing with them.

TemaSinergie 250px

Tema Sinergie is based in Faenza, Italy in the coastal province of Ravenna. The company's motto is "high tech, high care" and they have certainly been living up to that vision.  Tema specializes in nuclear medicine, radiotherapy, uro-oncology, barrier solution technology and medical physics. The group has been serving the country's need for medical products for over 30 years. Hyperthermia is an excellent extension of their product line and we are excited to have them on our team.

meyra turkey logo

Meyra Medicine and Health Products, will be bringing Pyrexar Medical's hyperthermia product line to Turkey. Meyra, which translates to "shining star" is headquartered outside the coastal city of Izmir in the town of Kemalpasa, Turkey. In addition to sales and service support of hyperthermia, the company is also involved in ultrasound imaging products and proton therapy systems. Turkey is an emerging market economy with a healthy medical technology sector.

Please join us in welcoming our new members to the Pyrexar team.

A friendly reminder that the main Hyperthermia conference events in the US and Europe, STM and ESHO, are right around the corner. These conferences are a gathering of the best in hyperthermia research and an excellent resource for those interested in the field of thermal oncology.

The 35th Annual Meeting of the Society for Thermal Medicine and the 32nd Annual Meeting of the European Society for Hyperthermic Oncology will provide an arena for presentations of latest data, concepts, and breakthroughs in our ever-expanding understanding of thermal medicine in the context of engineering, physics, materials science, and biology.

Keynote and Plenary speakers will highlight the extensive connections between physics, information science, biology, imaging, and the thermal state.

stm esho 2018

Who Should Attend?

  • Researchers in the field of thermal oncology
  • Clinicians, new to the field, who would like to talk with experts
  • Clinicians who want to expand their thermal oncology program
  • Medical Students that want to understand how hyperthermia may impact the future of medicine.
  • Pyrexar Distributors who want to expand their working knowledge of hyperthermia
  • Potential purchasers of hyperthermia equipment

Here are some dates to help you plan

  STM ESHO
Conference Dates: May 7-10 May 16-19
Location: Tuscon, Arizona Berlin, Germany
Venue: Westin La Paloma Resort Langenbeck-Virsho Hause
Abstract Deadline:  Feb 28th March 16th
Submit Abstract:
Early Bird Registration Deadline: Mar 16th Feb 28th
Conference Pass: $650 - $1300 € 350 - €500
Hotel: $109 €149 - €218
Show Website:

Hope to see you there!

A friendly reminder that the main Hyperthermia conference events in the US, Europe and ASIA, (STM, ESHO, ACHO) are right around the corner. These conferences are a gathering of the best in hyperthermia research and an excellent resource for those interested in the field of thermal oncology.

The 35th Annual Meeting of the Society for Thermal Medicine, 32nd Annual Meeting of the European Society for Hyperthermic Oncology and 7th Annual Asia Conference of Hyperthermic Oncology will provide an arena for presentations of latest data, concepts, and breakthroughs in our ever-expanding understanding of thermal medicine in the context of engineering, physics, materials science, and biology.

Keynote and Plenary speakers will highlight the extensive connections between physics, information science, biology, imaging, and the thermal state.

STM ESHO ACHO 2018

Who Should Attend?

  • Researchers in the field of thermal oncology
  • Clinicians, new to the field, who would like to talk with experts
  • Clinicians who want to expand their thermal oncology program
  • Medical Students that want to understand how hyperthermia may impact the future of medicine.
  • Pyrexar Distributors who want to expand their working knowledge of hyperthermia
  • Potential purchasers of hyperthermia equipment

Here are some dates to help you plan

  STM ESHO ACHO
Conference Dates: May 7-10 May 16-19 May 23-25
Location: Tuscon, Arizona Berlin, Germany Seoul, Korea
Venue: Westin La Paloma Resort Langenbeck-Virsho Hause The Catholic University
of Korea
Conference Pass: $650 - $1300 € 350 - €500 $235 USD
Hotel: $109 €149 - €218  
Show Website:

Hope to see you there!

A few facts that I learned during my visit to Kuwait; 1) gas is fifth cheapest in the world 2) the temperature can get hot enough to melt your tires and 3) the region has excellent healthcare resources.

A local distributor, MedVision, is looking to bring hyperthermia to Kuwait and the surrounding region. MedVision, a division of SADITA Holdings Group, is considered one of the fast growing companies in this field. Established in 2010 they are considered the market leaders in the territory, representing well known companies in the cardiology, cardiac surgery and peripheral intervention.

Physicians gathered at the Kuwait Cancer Center to learn about advancements in hyperthermia.  In addition to Mark Falkowski's Pyrexar's product overview presentation, MedVision invited hyperthermia expert and Director of the division of Translational Radiation Sciences at the University of Maryland School of Medicine, Dr. Zeljko Vujaskovic.

Ali Rabie, Senior Product Specialist, MedVision | Mark Falkowski, CEO - Pyrexar Medical | Ahmed El Ghamry, Business Unit Manager, MedVision

MedVision Headquarters, Safat, Kuwait

Dr. Zeljko Vujaskovic., Director of Translational Radiation Sciences at the University of Maryland School of Medicine

Oncologist gather at Kuwait Cancer Center to hear how hyperthermia can assist them in the treatment of cancer

ArrowArrow
Slider

Dr. Vujaskovic has published more than 150 articles and book chapters on radiation therapy, radiation injury, and hyperthermia topics. He has directed national and international research collaborations and is an active participant in cooperative group trials. He maintains an active clinical practice, with a focus on advanced treatment approaches in prostate cancer. His presentation “Principles of Hyperthermia in Cancer Treatment” was well received. "The more we can get oncologist engaged, the greater the chance hyperthermia will return to its place as a pillar of cancer treatment"

We are in negotiations with MedVision to become an authorized distributor for Kuwait with expansion into Qatar, Bahrain, Saudi Arabia, Lebanon, Jordan, Egypt, UAE, Oman, Iraq & Iran.

ORR 2018

A reminder that he ORR (Oncoradiology, Radiology and Radiotherapy) Congress will be held in Moscow, Russia at the Holiday Inn from February 16-17, 2018. Representing Pyrexar Medical's hyperthermia product line will be our distributor Sennewald Medizintechnik, GmbH.

screenshot oncoradiology.ru 2017 12 11 11 49 01The main goal of the conference is to provide a platform for radiodiagnosticians, radiotherapists and medical physicists for education, ideas and experience exchange, discussion of actual issues and professional communication. For the first time ever traditional conferences such as “Radiodiagnosis Standards in Oncology”, “Radiotherapy in Oncology”, “Medical Physics in Oncology”, “Interventional Radiology in Oncology”, “Radionuclide Therapy in Oncology” and the conference with international participation “PET in Oncology” will be considered within the same event. In addition, for the first time the conference “Ultrasonic Diagnosis in Oncology”, dedicated to the memory of Professor S. Balter will be performed and discussion site for fundamental and theoretical problems in radiobiology will be provided.

A link to registration can be found here.